Benchmark Litigation is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Position: Partner
Rating:
  • Litigation Star
Practice Areas:
Intellectual property
Languages:
English
Biography

Paul Browning, Ph.D., is a first chair litigator focusing on patent litigation and appeals, primarily in the chemical and pharmaceutical areas, including Hatch-Waxman (ANDA) litigation. He has tried cases before judges in various U.S. district courts and has handled arbitrations and mediations. He also advises on patent portfolio strategy with an eye toward success in litigation.

Paul’s broad litigation experience includes taking and cross-examining witnesses at trial, briefing and arguing dispositive motions, drafting appellate briefs, and arguing cases on appeal. He has also managed day-to-day litigation activities in actions involving multiple parties. In addition to his litigation practice, Paul advises clients on a variety of patent matters, including strategic development of their patent portfolios and coordination of prosecution and U.S. and foreign litigation strategy and related proceedings before the Patent Trial and Appeal Board.

Paul frequently lectures on various topics in chemical patent law. He designed laser systems and conducted spectroscopy of small molecules while earning master’s and doctorate degrees at the University of Chicago.

Paul devotes a portion of his practice to pro bono matters. He represents military personnel seeking enhanced compensation for injuries received while serving in the military, including injuries received in combat. He also represents veterans in cases before the U.S. Court of Appeals for Veterans Claims and the U.S. Court of Appeals for the Federal Circuit. 

Updated Dec 2025

Recent matter/case highlights
  • Representing Urovant Sciences GmbH, Sumitomo Pharma America, Inc. and Sumitomo Pharma, Inc. in patent litigations relating to Gemtesa®

  • Represented Biogen International GmbH in Hatch-Waxman litigations involving 28 companies seeking FDA approval to market generic versions of Tecfidera®

  • Represented Otsuka Pharmaceutical Co., Ltd. in 24 related Hatch-Waxman litigations concerning Otsuka’s Ability® tablet products 
Key practice areas
  • Appellate 
  • Intellectual Property 
Sector expertise
  • Pharmaceutical and life sciences 
Academic qualifications
  • J.D., cum laude - Harvard Law School (1999)
  • Ph.D., Chemistry - University of Chicago (1996)
  • M.S., Chemistry - University of Chicago (1993)
  •  B.S., Chemistry, magna cum laude - Brown University (1991)

 

 

Association/network memberships
  • National Veterans Legal Services Program (since 2023)
Bar Admissions
  • U.S. Patent and Trademark Office (2018)
  • District of Columbia (2000)
  • Massachusetts (1999)
  • U.S. District Court, D. Massachusetts (2020)
  • U.S. Court of Federal Claims (2015)
  • Supreme Court of the United States (2012)
  • U.S. Court of Appeals, Veterans Claims (2012)
  • U.S. Court of Appeals, Eleventh Circuit (2011)
  • U.S. Court of Appeals, Federal Circuit (2010)
Address:
901 New York Ave. NW
Washington, DC 20001
United States of America
Tel:+1 202 408 4134 Email:Contact this practitioner Website:finnegan.com